OE2.A2.1: Call for CDTI Mission in Advanced Therapies and Emerging Medicines (RNA) 2021
This call finances pre-competitive research projects in cooperation, led by companies in order to propose solutions to challenges of Spanish society through the promotion of public-private collaboration and the knowledge and technology base of Spanish companies. The health-related mission in the call for 2021 was identified as “Promoting the advancement and technological training of the Spanish biopharmaceutical industry to promote R&D actions in the field of advanced therapies, vaccines and targeted therapies.”
OE2.A2.2: ISCIII-CDTI Joint Call for Innovation linked to Personalized Medicine and Advanced Therapies 2022
This call promotes public-private collaboration of companies and research centers and agencies by co-leading initiatives related to three specific lines of action:
- Early and more accurate diagnosis
- Innovative and personalized treatment
- Improving the monitoring and rehabilitation of chronic diseases
